Empyrean Capital Partners’s Bristol-Myers Squibb Company Contingent Value Rights BMY.RT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-977,700
| Closed | -$675K | – | 213 |
|
|
2020
Q4 | $675K | Hold |
977,700
| – | – | 0.02% | 118 |
|
|
2020
Q3 | $2.2M | Sell |
977,700
-22,300
| -2% | -$50.2K | 0.09% | 72 |
|
|
2020
Q2 | $3.58M | Sell |
1,000,000
-286,200
| -22% | -$1.02M | 0.21% | 54 |
|
|
2020
Q1 | $4.89M | Sell |
1,286,200
-850,000
| -40% | -$3.23M | 0.34% | 42 |
|
|
2019
Q4 | $6.43M | Buy |
+2,136,200
| New | +$6.43M | 0.42% | 33 |
|